180 related articles for article (PubMed ID: 31765737)
41. High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.
Grellety T; Lucchesi C; Hostein I; Auzanneau C; Khalifa E; Soubeyran I; Italiano A
Eur J Cancer; 2017 Oct; 84():250-256. PubMed ID: 28841542
[TBL] [Abstract][Full Text] [Related]
42. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
[TBL] [Abstract][Full Text] [Related]
43. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G
Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370
[TBL] [Abstract][Full Text] [Related]
44. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.
San Lucas FA; Allenson K; Bernard V; Castillo J; Kim DU; Ellis K; Ehli EA; Davies GE; Petersen JL; Li D; Wolff R; Katz M; Varadhachary G; Wistuba I; Maitra A; Alvarez H
Ann Oncol; 2016 Apr; 27(4):635-41. PubMed ID: 26681674
[TBL] [Abstract][Full Text] [Related]
45. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
[TBL] [Abstract][Full Text] [Related]
46. The Mutational Signature Comprehensive Analysis Toolkit (musicatk) for the Discovery, Prediction, and Exploration of Mutational Signatures.
Chevalier A; Yang S; Khurshid Z; Sahelijo N; Tong T; Huggins JH; Yajima M; Campbell JD
Cancer Res; 2021 Dec; 81(23):5813-5817. PubMed ID: 34625425
[TBL] [Abstract][Full Text] [Related]
47. Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers.
Coutant C; Rouzier R; Qi Y; Lehmann-Che J; Bianchini G; Iwamoto T; Hortobagyi GN; Symmans WF; Uzan S; Andre F; de Thé H; Pusztai L
Clin Cancer Res; 2011 Apr; 17(8):2591-601. PubMed ID: 21248301
[TBL] [Abstract][Full Text] [Related]
48. Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type.
Koh J; Nam SK; Roh H; Kim J; Lee BC; Kim JW; Ahn SH; Park DJ; Kim HH; Park KU; Chung JH; Kim WH; Lee HS
Genes Chromosomes Cancer; 2019 Jan; 58(1):12-22. PubMed ID: 30239046
[TBL] [Abstract][Full Text] [Related]
49. Mutational signatures efficiently identify different mutational processes underlying cancers with similar somatic mutation spectra.
Zhou N; Yuan Y; Long X; Wu C; Bao J
Mutat Res; 2017 Dec; 806():27-30. PubMed ID: 28942182
[TBL] [Abstract][Full Text] [Related]
50. Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity.
Grünewald I; Vollbrecht C; Meinrath J; Meyer MF; Heukamp LC; Drebber U; Quaas A; Beutner D; Hüttenbrink KB; Wardelmann E; Hartmann W; Büttner R; Odenthal M; Stenner M
Oncotarget; 2015 Jul; 6(20):18224-37. PubMed ID: 26053092
[TBL] [Abstract][Full Text] [Related]
51. [Immune response and digestive cancers: Prognostic and therapeutic implications].
Bibeau F; Bazille C; Svrcek M; Pierson R; Lagorce-Pagès C; Cohen R; André T
Ann Pathol; 2017 Feb; 37(1):111-116. PubMed ID: 28111038
[TBL] [Abstract][Full Text] [Related]
52. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
[TBL] [Abstract][Full Text] [Related]
53. Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas.
Harthimmer MR; Stolborg U; Pfeiffer P; Mortensen MB; Fristrup C; Detlefsen S
J Clin Pathol; 2019 Nov; 72(11):762-770. PubMed ID: 31256008
[TBL] [Abstract][Full Text] [Related]
54. Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma.
Ringnér M; Staaf J
Oncotarget; 2016 Aug; 7(33):52957-52973. PubMed ID: 27437773
[TBL] [Abstract][Full Text] [Related]
55. Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question.
Lai BR; Wu YT; Kuo YC; Hsu HC; Chen JS; Chen TC; Wu RC; Chiu CT; Yeh CN; Yeh TS
Oncotarget; 2016 Dec; 7(50):83270-83277. PubMed ID: 27806309
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of peripheral blood-derived neutrophil/lymphocyte ratio in patients with digestive cancer.
Liu F; Luo H; Zhu Z; Zhu P; Huang J
J Cell Physiol; 2019 Dec; 234(12):22775-22786. PubMed ID: 31140613
[TBL] [Abstract][Full Text] [Related]
57. [Problems raised by screening for digestive tract superficial neoplastic lesions].
Lambert R; Parkin DM
Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B103-8. PubMed ID: 10891773
[No Abstract] [Full Text] [Related]
58. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
59. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
60. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
